In his "Defense of Antidepressants" in last Sunday's New York Times, Peter Kramer tried to discredit meta-analyses of SSRI antidepressants indicating that most of their efficacy is due to placebo, to ...

Many patients end up "parked" on antidepressant meds. It can be tough to quit on your own. Withdrawal symptoms can range from mild to severe. A first-of-its-kind microdosing service is opening in the ...

Antidepressants are one of the most commonly taken medicines in the UK – and also among the most controversial. A common concern for users is that they will get “hooked” on the pills because stopping ...

The world of depression treatment options is vast, varied and confusing at times. So many antidepressant medications, so many types of therapy, so many acronyms and so much information. In all the ...

Nigel Mulligan does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...